GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $97,070,000 | +4593.9% | 2,228,500 | +3865.9% | 0.18% | +1572.7% |
| Q4 2020 | $2,068,000 | -87.7% | 56,192 | -87.4% | 0.01% | -89.7% |
| Q3 2020 | $16,789,000 | +729.1% | 446,052 | +798.5% | 0.11% | +664.3% |
| Q2 2020 | $2,025,000 | -46.5% | 49,646 | -44.0% | 0.01% | -53.3% |
| Q3 2019 | $3,782,000 | +3923.4% | 88,610 | +3841.7% | 0.03% | – |
| Q1 2019 | $94,000 | +118.6% | 2,248 | +100.0% | 0.00% | – |
| Q4 2018 | $43,000 | -81.0% | 1,124 | -82.4% | 0.00% | -100.0% |
| Q4 2017 | $226,000 | -87.2% | 6,374 | -85.1% | 0.01% | -89.0% |
| Q3 2017 | $1,760,000 | +124.2% | 42,922 | +135.1% | 0.08% | +134.3% |
| Q2 2017 | $785,000 | -98.1% | 18,259 | -98.3% | 0.04% | -86.8% |
| Q4 2016 | $40,493,000 | +19.7% | 1,051,489 | +34.1% | 0.27% | +10.4% |
| Q3 2016 | $33,829,000 | +1137.8% | 784,359 | +1003.4% | 0.24% | +608.8% |
| Q3 2015 | $2,733,000 | – | 71,084 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |